U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday.The Dow traded up 1.20% to 47,007.17 while the NASDAQ rose 0.48% to 22,980.75. The S&P 500 also rose, gaining, 0.74% to 6,754.86.Check This Out: Jim Cramer: This Communication Services Stock Is A Buy, Recommends Holding On To Howmet AerospaceLeading and Lagging SectorsHealth care shares jumped by 2% on Tuesday.In trading on Tuesday, energy stocks fell by 0.9%.Top HeadlineU.S. retail sales rose ...

PresentationGood morning, ladies and gentlemen, and thank you for standing by. Welcome to the Zynex Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Vikram Bajaj, Chief Financial Officer of Zynex. Please go ahead.Vikram BajajChief Financial Officer Thank you, operator, and good afternoon, everyone. Yesterday, we released financial results for the third quarter September 30, 2025. A copy of t ...

Core Insights - Nautilus Biotechnology, Inc. reported its financial results for Q2 2025, highlighting key performance metrics and future outlook [3]. Financial Performance - The earnings call was held on July 31, 2025, at 8:30 AM ET, with participation from key executives including the CEO and CFO [1]. - The company released its financial results for the quarter ended June 30, 2025, indicating a focus on transparency and communication with investors [3]. Management Commentary - The management team, including the CEO and Chief Scientist, provided insights into the company's strategic direction and operational updates during the call [1][3]. - Forward-looking statements were made regarding the company's future performance, emphasizing the potential for growth and innovation in the biotechnology sector [4].